(Q57994792)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353258%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Development of a recombinant cell-based system for the characterisation of phosphodiesterase 4 isoforms and evaluation of inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353258%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353258%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

R A Allen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353258%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M W Merriman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353258%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M J Perry

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353258%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353258%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353258%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353258%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1375-1382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353258%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353258%20AND%20SRC:MED&resulttype=core&format=json

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Phosphodiesterase inhibitors: new opportunities for the treatment of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Differential CNS expression of alternative mRNA isoforms of the mammalian genes encoding cAMP-specific phosphodiesterases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

PDE 4 inhibitors: the use of molecular cloning in the design and development of novel drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Human phosphodiesterase 4A: characterization of full-length and truncated enzymes expressed in COS cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Molecular cloning and expression of a human phosphodiesterase 4C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Identification of cyclic AMP-phosphodiesterase variants from the PDE4D gene expressed in human peripheral mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

The use of engineered E1A genes to transactivate the hCMV-MIE promoter in permanent CHO cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

CDP840: a novel inhibitor of PDE-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Stereospecific binding of the antidepressant rolipram to brain protein structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Functional coupling of endogenous serotonin (5-HT1B) and calcitonin (C1a) receptors in CHO cells to a cyclic AMP-responsive luciferase reporter gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

Calcium-independent phosphodiesterase inhibitors as putative antidepressants: [3-(bicycloalkyloxy)-4-methoxyphenyl]-2-imidazolidinones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900062-3

10.1016/S0006-2952(99)00062-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353258%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference